References

Baccarini M. (2002) An old kinase on a new path: Raf and apoptosis. Cell Death Differ 9, 783–785

Barrera-Vilarmau S., Obregon P., de Alba E. (2011) Intrinsic order and disorder in the bcl-2 member harakiri: insights into its propoptotic activity. PLoS One6, e21413

Bharatham N., Chi SW., Yoon HS. (2011) Molecular basis of BCL-xL-p53 interaction: insights from molecular dynamic simulation. PLoSOne6, e26014

Biroccio A., Candiloro A., Mottolese M., Sapora O., Albini A., Zupi G., Del Bufalo D. (2000) Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. The FASEB Jounral 14, 652-660

Campone M., et al. (2011) c-Myc dependent expression of pro-apoptotic BIM renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1. Mol Cancer10, 110

Chen D., Zhou Q. (2004) Caspase cleave of BimEL triggers a positive feedback amplification of apoptotic signalling. PNAS 101, 1235-1240

Chen L., et al. (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17, 393-403

Chinnadurai G., Vijayalingam S., Rashmi R. (2008) BIK, the founding member of the BH-3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene Supplement, S20-S29

Chipuk J.E., et al. (2008) Mechanisms of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. PNAS106, 20327-20332

Chipuk J.E., et al. (2010) The BCL-2 family reunion. Mol Cell 37, 299-310

Cogliati S., Scorrano L. (2010) A BID on mitochondria with MTCH2.Cell Research20, 863-865

Crawford A., Nahta R. (2011) Targeting Bcl-2 in Herceptin-resistant breast cancer cell lines.Curr Pharmacogenomics Person Med9, 184-190

Dai H., et al. (2011) Transient binding of an activator BH3 domain to the Bak BH3-binding groove initates Bak oligomerization. J. Cell Biol194, 39-48

Datta S.R., et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell91, 231-241

Del Gaizo Moore V.D.G., et al. (2007) Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J Clin Invest 117, 112-121

Dewson G., et al. (2009) Bak activation for apoptosis involves oligomerisation of dimmers via their alpha6 helices. Mol Cell36, 696-703

Dudgeon C., Wang P., Sun X., Peng R., Sun Q., Yu J., Zhang L. (2010) PUMA induction by FoxO3a mediates the anticancer activities of the broad-range kinase inhibitor UCN-01. Mol Cancer Ther 9, 2893-2902

Elkholi R., Floros K.V., Chipuk J.E. (2011) The role of BH3-only proteins in Tumour Cell Development Signalling, and treatment. Genes and Cancer2, 523-537

Fricker M., O’Prey J., Tolkovsky A.M., Ryan K.M. (2010) Phosphorylation of PUMA modulates its apoptotic function by regulating protein stability. Cell death Dis1, e59

Fu N.Y., Sukumaran S.K., Kerk S.Y., Yu V.C. (2009) Baxbeta: a constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation method. Mol Cell33, 15-29

Gao J., Senthil M., Ren B., Yan J., Xing Q., Yu J., Zhang L., Yim J.H. (2010) IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1 induced apoptosis in cancer cells. Cell Death Differ17, 699-709

Garrison S.P., et al. (2011) Genetically defining the mechanism of Puma- and Bim-induced apoptotis. Cell Death Differ Epub, Ahead of print

Gavthiotis E., et al. (2008) BAX activation is initiated at a novel interaction site. Nature455, 1076-1081

Gonzalvez F., et al. (2008) Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol183, 681-696

Gonzalvez F., et al. (2010) Mechanistic issues of the interaction of the hairpin-forming domain of tBID with mitochondrial Cardiolipon. PLoS One5, e9342

Han J., Goldstein L.A., Hou W., Gastman B.R., Rabinowich H. (2010) Regulation of mitochondrial apoptotic events by p53-mediated disruption of complexes between antiapoptotic Bcl-2 members and Bim. J Biol Chem285, 22473-22483

Hekman M., et al. (2006) Reversible membrane interaction of BAD requires two C-terminal lipid binding domains in conjunction with 14-3-3 protein binding. J Biol Chem281, 17321-17336

Hershko T., Ginsberg D. (2004) Up-regulation of BCL-2 homology 3 (BH3)-only protein by E2F1 mediates apoptosis. J Biol Chem279, 8627-8634

Hinds M.G., Smits C., Fredericks-Short R., Risk J.M., Bailey M., Huang D.C., Day C.L. (2007) Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformation change upon binding to prosurvival Bcl-2 targets. Cell Death Differ14, 128-136

Hubner A., Barrett T., Flavell R.A., Davis R.J. (2008) Multisite phosphorylation regulates Bim stability and apoptotic activity. Mol Cell30, 415-425

Hur J., et al. (2006) Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein. Cancer Res 66, 10153-10161

Hu W., et al. (2012) PRO-APOPTOTIC PROTEIN, SMAC, MEDIATES APOPTOSIS IN CISPLATIN-RESISTANT OVARIAN CANCER CELLS WHEN TREATED WITH THE ANTI-TUMOR AGENT, AT101 J Biol Chem287, 68-80

Inohara N., Ding L., Chen S., Nunez G. (1997) Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-xL. EMBO J16, 1686-1694

Jiang P., Du W., Heese K., Wu M. (2006) The Bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis. Mol Cell Biol26, 9071-9082

Jin S., Zhuo Y., Guo W., Field J. (2005) p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association. J Biol Chem280, 24698-24707

Kim H., et al. (2009) Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell36, 487-499

Kolluri S.K., et al (2008) A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell14 285-298

Kutuk O., Letai A. (2010) Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel induced apoptosis in breast cancer cells. Cell Death Differ17, 1624-1635

Lazarou M., et al. (2010) Inhibition of BaK Activation by VDAC2 is dependent on the Bak transmembrane anchor. J Biol Chem285, 36876-36883

Leber B., Lin J., Andrews D.W. (2007) Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis12, 897-911

Lei K., Davis R.J. (2003) JNK phosphorylation of Bim-related members of the Bcl-2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A100, 2432-2437

Li Y.Z., Lu D.Y., Tan W.Q., Wang J.X., Li P.F. (2008) p53 initiates apoptosis by trancriptionally targeting the antiapoptotic protein ARC. Mol Cell Biol 28, 564-574

Lovell J.F., et al. (2008) Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell135, 1074-1084

Merino D., et al. (2009) Therole of BH3-only protein Bim extends beyond inhibiting Bcl-2-like prosurvival proteins.

Meunier J., Hayashi T. (2010) Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaβ. J Pharmacol Exp Ther332, 388-397

Moujalled D., et al (2011) Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim. EMBO Rep12, 77-83

Niture S.K., Jaiswal A.K. (2011) INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis. Cell Death Differ18, 439-451

Oda E., et al. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science288, 1053-1058

Peng J., et al. (2009) Oligomerization of membrane-bound Bcl-2 is involved in its pore formation induced by tBID. Apoptosis14,1145-1153

Pinon J.D., Labi V., Egle A., Villunger A. (2008) Bim and Bmf in tissue homeostasis and malignant disease.OncogeneSupplement, s41-s52

Polzien L., et al. (2009) Identification of novel in vivo phosphorylation sites of the human proapoptotic protein BAD: pore-forming activity of BAD is regulated by phosphorylation. J Biol Chem284, 28004-28020

Puthalakath H., et al. (2001) Bmf: A proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science293, 1829-1832

Real P.J., et al. (2006) Transcriptional activation of the pro-apoptotic bik gene by E2F proteins in cancer cells. Febbs Lett580, 5905-5909

Rodriguez J.M., Glozak M.A., Ma Y., Cress W.D. (2006) Bok, Bcl-2-related Ovarian Killer, is cell cycle-regulated and sensitizes to stress-induced apoptosis. J Biol Chem2006, 22729-22735

Rubenstein M., et al (2011) In LNCaP cells enhanced expression of the androgen receptor compensates for Bcl-2 suppression by antisense oligonucleotides Ther Adv Urol3, 51-57

Sakamaki J., et al. (2011) Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt. Proc Natl Acad Sci U S A108, 6085-6090

Sborgi L., Barrera-Vilarmau S., Obregon P., de Alba E. (2010) Characterization of a novel interaction between Bcl-2 members Diva and Harakiri. PLos One5, e15575

Shao Y., Aplin A.E. (2012) ERK2 phosphorylation of serine 77 regulates Bmf pro-apoptotic activity. Cell Death Dis3, e253

Shelton S.N., Shawgo M.E., Robertson J.D. (2009) Cleavage of Bid by executioner caspases mediates feed forward amplification of mitochondrial outer membrane permeabilization during genotoxic stress-induced apoptosis in Jurkat cells. J Biol Chem284, 11247-11255

Thompson J., Winoto A. (2008) During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its pro-apoptotic BH3 domain. J Exp Med205, 1029-1036

Upreti M., Chu R., Galitovskaya E, Smart S.K., Chambers T.C. (2008) Key role for Bak activation and Bak-Bax interaction in the apoptotic response to vinblastine. Mol Cancer Ther7, 2224-2232

Verma S., Zhao L.J., Chinnadurai G. (2001) Phosphorylation of the pro-apoptotic protein BIK: mapping the phosphorylation sites and effect on apoptosis. J Biol Chem276, 4671-4676

Wang H., et al. (1996) Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell87, 629–638

Wang P., Yu J., Zhang L. (2007) The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage. Proc Natl Acad Sci U S A104, 4054-4059

Wang Y., et al. (2008) A novel member of the Rhomboid family, RHBDD1, regulates BIK-mediated apoptosis. Cell Mol Life Sci65, 3822-3829

Wee K.B., Surana U., Aguda B.D. (2009) Oscillations of the p53-Akt network: implications on cell survival and death. PLos One4, e4407

Wiggins C.M., et al. (2011) BIM(EL), an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation. J Cell Sci124, 969-977

Wu W.S., et al. (2005) Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell123, 641-653

Ye Z. D., et al. (2011) p21-Activated Kinase 1 (Pak1) Phosphorylates BAD Directly at Serine 111 In Vitro and Indirectly through Raf-1 at Serine 112. PLoS One6, e27637

Yu J., Zhang L. (2008) PUMA, a potent killer with or without p53. OncogeneSupplement, S71-S83

Zaltsman Y., et al. (2010) MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria. Nat Cell Biol12, 553-562

Zhang L., et al. (2011) Selective involvement of BH-3-only proteins and differential targets of Noxa in diverse apoptotic pathways. Cell Death Differ18, 864-873

Zhang K., et al. (2011) RNA interference targeting SLUG increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA. Int J Mol Sci 12, 385-400

Zhao L., et al. (2011) A natural compound elevates expression of Bim that interacts with Bcl-2 converting the anti-apoptotic protein to a pro-apoptotic Bax-like molecule. J Biol Chem287, 1054-1065

Use pubmed to search for papers.